Oger Ophtalmologie SRL

Oger Ophtalmologie reported total assets of 107,747 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Nov 2025).

Company number (CBE) 0823.621.852 · VAT BE0823621852
1420 Braine-l'Alleud
active in Medical specialists activities (NACE 86220)
operating since 04 Mar 2010 (≈ 16 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Oger Ophtalmologie shows with a free account.

See the score
Profile
SRL since 2010
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result45,885 €
Equity54,386 €
Cash43,305 €
EBITDA79,162 €
Total assets107,747 €
The line marks its sector median: 65.0% (4535 companies).

Change 2022 → 2025: Equity -20 % Total assets -12 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Oger Ophtalmologie's annual accounts

20252024202320222021
Net result45,885 €
Equity54,386 €
Cash43,305 €
EBITDA79,162 €
Total assets107,747 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 04 Nov 2025
  • Year ended 30 Jun 2024filed on 25 Nov 2024
  • Year ended 30 Jun 2023filed on 15 Dec 2023
  • Year ended 30 Jun 2022filed on 12 Dec 2022
  • Year ended 30 Jun 2021filed on 25 Jan 2022

Oger Ophtalmologie's financial analysis

Management and control of Oger Ophtalmologie

1 active director(s) in the register.

Oger Ophtalmologie's shareholders and holdings →

Oger Ophtalmologie's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0823.621.852
VAT number
BE0823621852
Peppol
Registered · 0208:0823621852 · as of 10 Nov 2026
Legal form
SRL
Incorporated
04 Mar 2010
Registered office
1420 Braine-l'Alleud
Latest accounts
2025 · filed on 04 Nov 2025
Activity
Medical specialists activities (NACE 86220)

Oger Ophtalmologie (SRL) has been based in Braine-l'Alleud since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 45,885 € and equity of 54,386 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Oger Ophtalmologie

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Oger Ophtalmologie

What is the revenue of Oger Ophtalmologie?

Oger Ophtalmologie files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Oger Ophtalmologie?

In Belgium, the VAT number is the company number prefixed with BE: BE0823621852 for Oger Ophtalmologie, if the company is VAT-registered. Its company number (CBE) is 0823.621.852.

Where is the registered office of Oger Ophtalmologie?

According to the CBE register, the registered office of Oger Ophtalmologie is in 1420 Braine-l'Alleud.

What is the equity of Oger Ophtalmologie?

At the close of the 2025 financial year, the equity of Oger Ophtalmologie amounts to 54,386 €, a solvency of 50.5% of total assets.

Who manages Oger Ophtalmologie?

The register lists 1 active mandates at Oger Ophtalmologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Oger Ophtalmologie

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 26 Aug 2026

No credit card, no commitment.

What each plan unlocks →